Alprazolam
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Anxiety | Phase 3 |
SP0829
Completed |
NCT00139854 | ||||
| Mild Asthma | A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma | Phase 1 |
UP0099
Completed |
NCT04802746 | Miller S.D. et al. (2023) [abstract 2.255] 77th Annual Meeting of American Epilepsy Society (AES), December 01-05, 2023; Orlando, USA AES Annual Meeting Abstract Database. www.aesnet.org | ||
| Epilepsy | A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy | Phase 1 |
UP0100
Completed |
NCT04857307 2022-002523-36 |
LINK
|
Klein P. et al. (2023) [abstract 2.261] 77th Annual Meeting of American Epilepsy Society (AES), December 01-05, 2023; Orlando, USA AES Annual Meeting Abstract Database. www.aesnet.org | |
| Epilepsy | A Relative Bioavailability Study of Staccato Alprazolam Versus Oral Alprazolam in Healthy Study Participants | Phase 1 |
UP0104
Completed |
NCT05626439 |